CEO David Jenkins Buys 9,489 Shares of Catheter Precision’s New Preferred Stock Amid 18‑Year‑Old Decline—A Quiet Bet on Future Growth
Insider buying alert: Catheter Precision’s CEO buys Series J Preferred shares after a $36.5 M funding round, hinting confidence amid steep stock decline.
3 minutes to read